Arabian International Healthcare Holding Company (TADAWUL:9530)
Saudi Arabia · Delayed Price · Currency is SAR 18.06
+0.19 (1.06%)
Oct 15, 2026, 2:26 PM AST
TADAWUL:9530 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 357 | 445 | 792 | 789 | 742 | - | |
Market Cap Growth | -45.27% | -43.77% | 0.38% | 6.29% | - | - |
Enterprise Value | 726 | 940 | 1,300 | 1,268 | 1,094 | - |
Last Close Price | 18.06 | 22.49 | 40.00 | 39.85 | 36.22 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.53 | 18.86 | - | 20.71 | 36.24 | - |
PS Ratio | 0.43 | 0.53 | 1.07 | 0.98 | 1.16 | - |
PB Ratio | 1.03 | 1.22 | 2.70 | 2.19 | 2.19 | - |
P/TBV Ratio | 1.05 | 1.23 | 3.66 | 4.23 | 5.07 | - |
P/FCF Ratio | 7.41 | - | 7.74 | 187.53 | 12.91 | - |
P/OCF Ratio | 6.95 | 276.13 | 7.49 | 65.21 | 12.33 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.86 | 1.12 | 1.76 | 1.57 | 1.70 | - |
EV/EBITDA Ratio | 8.27 | 10.95 | 21.33 | 18.40 | 18.68 | - |
EV/EBIT Ratio | 9.32 | 12.42 | 25.96 | 21.19 | 20.42 | - |
EV/FCF Ratio | 15.07 | - | 12.71 | 301.46 | 19.03 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.12 | 1.22 | 1.88 | 1.47 | 1.51 | 0.86 |
Debt / EBITDA Ratio | 4.36 | 4.77 | 8.13 | 7.05 | 8.06 | 3.24 |
Debt / FCF Ratio | 8.08 | - | 5.37 | 125.76 | 8.90 | 2.22 |
Net Debt / Equity Ratio | 1.07 | 1.20 | 1.60 | 1.24 | 1.27 | 0.83 |
Net Debt / EBITDA Ratio | 4.44 | 5.12 | 7.70 | 6.48 | 7.31 | 3.25 |
Net Debt / FCF Ratio | 7.65 | -212.03 | 4.59 | 106.17 | 7.45 | 2.13 |
Asset Turnover | 0.65 | 0.63 | 0.54 | 0.57 | 0.53 | 0.53 |
Inventory Turnover | 1.86 | 2.00 | 2.15 | 2.32 | 1.99 | 2.29 |
Quick Ratio | 0.91 | 0.90 | 1.03 | 1.20 | 0.89 | 1.32 |
Current Ratio | 1.46 | 1.47 | 1.43 | 1.56 | 1.27 | 1.73 |
Return on Equity (ROE) | 9.03% | 8.69% | -19.11% | 12.14% | 7.65% | 24.73% |
Return on Assets (ROA) | 3.84% | 3.52% | 2.27% | 2.66% | 2.75% | 4.34% |
Return on Invested Capital (ROIC) | 8.41% | 7.12% | 6.39% | 5.97% | 5.47% | 11.04% |
Return on Capital Employed (ROCE) | 17.60% | 14.60% | 9.40% | 8.70% | 10.20% | 17.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.13% | 5.30% | -8.42% | 4.83% | 2.76% | - |
FCF Yield | 13.49% | -0.47% | 12.92% | 0.53% | 7.75% | - |
Dividend Yield | - | - | - | - | 2.67% | - |
Payout Ratio | 42.15% | 51.91% | - | 51.96% | 293.05% | 100.45% |
Buyback Yield / Dilution | - | - | - | 0.94% | 0.11% | -1430.22% |
Total Shareholder Return | - | - | - | 0.94% | 2.78% | -1430.22% |